Discussion
Mental health
In the present study, 41.2% of the players reported moderate or higher symptoms of at least one MHP (anxiety, depression or sleep difficulties). Compared with the prevalence of comorbidities at 19.2%, this illustrates that comorbidities were represented in almost half of the cases. This can highlight the importance of acknowledging comorbidities of anxiety, depression and sleep difficulties, which are MH states with strong positive relations shown in recent research on elite athletes.11 Notably, out of the 19.2% with comorbidities, 14.8% had sleep difficulties, indicating that sleep difficulties are a big part of comorbid cases and should be addressed. If not, comorbid MHP symptoms such as anxiety and depression will unlikely dissolve.1
Symptoms of sleep difficulties were most frequently reported, with a prevalence rate of 29.7% for moderate or severe symptom levels. This is somewhat higher than the percentages from a systematic review of athletes from various sports and contexts, showing a prevalence rate of sleep disturbances at 26% among female and male athletes.25 The result from the present study adds to the existing empirical evidence on the common prevalence of sleep problems in high-level athletes and the need to target them.10 Within the league it is a mix of games played between lunch time (game starts and 12:00) and the evening (19:00). There is also a mix of overnight stays versus travel back home the same night when playing away games. For the present study population, addressing sleep difficulties can be of certain interest due to the inevitable travel associated with competition, which in previous consensus statements has been presented as a primary risk factor for sleep disturbances. Additionally, it is highlighted in the consensus statements that sleep in elite athletes is an essential part of both their mental and physical health.10
For anxiety symptoms, 20.9% of the respondents in the present study reported moderate or higher levels. For symptoms of depression, 18.1% reported moderate or higher levels. The percentages from the present study correspond to a previous Swedish study, which included a similar population consisting of female players in top leagues in soccer, handball and ice hockey. The COVID-19 pandemic was present in that study, and COVID-19-related worries were associated with anxiety and depression among the athletes.2 COVID-19 restrictions were not present when the present study was conducted. Instead, it was conducted during the competitive season, which can come with different stressors that may affect MH, such as travel, external expectations and media.26 Also, performance-related stressors might be of particular importance given the time of the season when the study was conducted.27
Among the respondents in the present study, 60.2% reported flourishing MH, meaning experiencing a good MH with optimal functioning, including emotional, social and psychological well-being.12 22 The percentage in the present study is notably higher than in a Canadian study, showing 44–45%.28 It should be noted that the population in the Canadian study were both male and female student-athletes from a wide variety of sports, in comparison with the present study with athletes from a specific sport without the specific university context, meaning the contextual factors differ between the populations which could influence the MH prevalence.29 Even though the percentages from the present study could be interpreted as relatively high, it should be noted that the ISSP states that the ideal state is experiencing flourishing MH without symptoms of MHP (ie, symptoms of anxiety, depression or sleep problems),12 which was reported among about 40.3% in the present study. As follows, 59.7% were not reaching the ideal state of MH, either due to not having a flourishing MH or the presence of symptoms of MHP.
Associations with risk, protective factors and promotive factors
In this study, PF was the variable with the most associations with MH and the symptoms of MHP. More specifically, higher levels of PF were associated with flourishing MH, and lower levels of PF were associated with symptoms of depression, anxiety and sleep difficulties. This indicates that PF can be suggested as a promotive and protective factor in this context. The negative association between PF and anxiety corresponds with previous research with male elite soccer players in Portugal participating in an intervention inspired by acceptance and commitment therapy programmes.16 Other research has further shown that PF enhances MH directly, both decreasing anxiety and depression, as well as enhancing social functioning,30 which may explain the associations found in the present study. The findings in this study can add to recent research highlighting the relevance of working towards promoting PF in athlete populations. For instance, a randomised controlled trial study with female student-athletes has shown that participation in interventions to increase PF reduces psychological, emotional and behavioural concerns.31
The results of the present study also showed that higher PSS was associated with higher odds of flourishing MH. Similarly, a recent Danish study showed that elite athletes with above-average mental well-being received higher support than athletes with low mental well-being.32 The associations presented in the present study can be understood through recent research with a German working population where it was suggested that social support facilitates the enforcement of mental well-being, even when multimorbidity is present.33 The association between lower PSS and symptoms of sleep difficulties was a more unexpected finding. However, this correlation corresponds with recent research on Dutch elite athletes.34 The association between PSS and sleep is theorised by other scholars with a suggestive explanation that ‘social support may influence sleep through the meaning that people derive from their supportive social ties and how meaning promotes better mental health’35 (p 153). The present study supports previous research on elite athletes presenting low social support as a risk factor and high social support as a protective factor for MH,14 as well as its positive association with mental well-being,32 suggesting that it can also be understood as a promotive factor.
In the discussion of protective factors, it is important to state that even if we, in the current study, have focused on athlete (PF) as well as interpersonal (social support) aspects, organisational as well as societal factors also influence both the risk for MHP as well as the athletes’ chances of coping with potential stressors. It is, therefore, important for different stakeholders to work actively with strategies that could help the athlete to cope with the potential stressors to facilitate health and performance.
Clinical implications
This study mapped MH among players in the SDHL. The prevalence of symptoms of anxiety, depression and sleep difficulties reported in this study should be acknowledged, considering that the mapping and early identification of MHP is an important prevention strategy.12 Likewise, the prevalence rates also indicate where further assessment and management are needed. Moreover, this study gives insight into the prevalence of a subideal MH state, indicating a promotion gap. Additionally, this study identifies PF and PSS as protective and promotive factors that could be beneficial to prevent MHP and promote MH. The findings in this study can be valuable for promoting MH in this elite athlete population, which in turn can be understood as a key resource for a healthy and prosperous sports system.29 Different initiatives to facilitate MH are important to consider for stakeholders.13 Such initiative could, for example, be to educate stakeholders about both how to facilitate MH and how to identify signs of MHP. Also, for the organisation to screen for MHP, using, for example, the IOC Sport Mental Health Assessment Tool 136 to detect athletes who need help can be of great importance. In this process, it is also important for the organisation to have connection with psychologists to refer athletes who need treatment for MHP. This can, in turn, be valuable, considering that sport is a powerful platform for promoting MH and gender equality, especially within high-level sports where such work can serve as a model for society at large.1 37
Limitations and strengths
Considering the cross-sectional design of this study, causal relationships cannot be determined. This study only investigated the point prevalence of MH status during the competitive season. It should be noted that the prevalence could differ during the off-season. Therefore, it can be suggested that future research observing MH status and associated factors over time is needed. A strength of this study was the high response rate, contributing to higher quality and accuracy of the data, making the sample much more representative. Another strength is that both MI and MH were investigated, contributing to a fuller picture of the MH status of the studied population.